The Chief Commercial Officer at the Department of Health and Social Care (DHSC), Steve Oldfield, has written to industry with an update on the Government’s ongoing contingency planning for Brexit, in particular its National Supply Disruption Response (NSDR).
The NSDR team is based with NHS Business Services, and includes a dedicated contact line for companies to report actual or expected disruption to supply routes. The NSDR is responsible for coordinating this information, and prioritisation of official response capacity. The NSDR will link industry with Government response efforts such as additional contracted freight capacity and potential fast-tracking of critical supplies through border checks.
Where possible, the letter encourages companies to report issues via existing routes. Continued stockpiling of medicines by industry is also encouraged.
DHSC has also written to clinical trial sponsors to highlight the potential impacts of supply chain issues on trials. This communication covers similar ground, outlining responses and coordination routes. The letter also highlights DHSC expectations that NHS sites should not be asked to stockpile supplies for trials conducted there, and that any contingency preparation, including product storage, should be conducted by the sponsor organisation.